American Cancer Society Journals shared on LinkedIn:
“New in Cancer, How can we reduce gynecologic cancer–related deaths in low- and middle-income countries?
Low – and middle-income countries (LMICs) bear a disproportionate burden of gynecologic malignancies – cancers of the cervix, endometrium, ovary, vagina, and vulva.
This new review reveals that survival disparities for these cancers are driven by late-stage diagnosis, limited screening coverage, inadequate radiotherapy infrastructure, workforce shortages, and restricted access to essential and novel therapies.
‘The survival gap in gynecologic cancers between low- and middle-income countries and wealthier nations is not inevitable – it is largely the result of delayed diagnosis and under-resourced health systems,’ said corresponding author Dr. Alfi Sophian, SSi, MSi, of the Indonesian Food and Drug Authority.
‘Our review shows that proven, cost-effective interventions already exist. What is needed now is stronger political commitment and sustainable financing to embed them into national cancer control policies.’
Cancer’s Editor-in-Chief, Suresh S. Ramalingam, MD, FASCO, who is the Executive Director of the Winship Cancer Institute of Emory University and the Roberto C. Goizueta Chair in Cancer Research at the Emory University School of Medicine, agreed that the review highlights key opportunities to reduce the burden of gynecological malignancies in low- and middle-income countries.
‘Gynecological malignancies claim the lives of far too many women globally; implementation of evidence-based tools consistently and uniformly across the world will save numerous lives,’ he said.”
Title: Gynecologic cancers in low- and middle-income countries: Bridging the survival gap
Authors: Dewi Setiawati SpOG, Wachyudi Muchsin SKed, SH, MKes, CMed, Alfi Sophan SSi, MSi
You can also read: SGO 2027 Annual Meeting on Gynecologic Cancer
